Design of a New Vaccine Prototype against Porcine Circovirus Type 2 (PCV2), M. hyopneumoniae and M. hyorhinis Based on Multiple Antigens Microencapsulation with Sulfated Chitosan
dc.contributor.author | Arrieta-Mendoza, Darwuin | |
dc.contributor.author | Garces, Bruno | |
dc.contributor.author | Hidalgo, Alejandro A. | |
dc.contributor.author | Neira, Victor | |
dc.contributor.author | Ramirez, Galia | |
dc.contributor.author | Neira-Carrillo, Andrónico | |
dc.contributor.author | Bucarey, Sergio A. | |
dc.date.accessioned | 2024-07-19T14:07:11Z | |
dc.date.available | 2024-07-19T14:07:11Z | |
dc.date.issued | 2024-05 | |
dc.description | Indexación: Scopus. | |
dc.description.abstract | This work evaluated in vivo an experimental-multivalent-vaccine (EMV) based on three Porcine Respiratory Complex (PRC)-associated antigens: Porcine Circovirus Type 2 (PCV2), M. hyopneumoniae (Mhyop) and M. hyorhinis (Mhyor), microencapsulated with sulfated chitosan (M- ChS + PRC-antigens), postulating chitosan sulphate (ChS) as a mimetic of the heparan sulfate receptor used by these pathogens for cell invasion. The EMV was evaluated physicochemically by SEM (Scanning-Electron-Microscopy), EDS (Energy-Dispersive-Spectroscopy), Pdi (Polydispersity-Index) and zeta potential. Twenty weaned pigs, distributed in four groups, were evaluated for 12 weeks. The groups 1 through 4 were as follows: 1-EMV intramuscular-route (IM), 2-EMV oral-nasal-route (O/N), 3-Placebo O/N (M-ChS without antigens), 4-Commercial-vaccine PCV2-Mhyop. qPCR was used to evaluate viral/bacterial load from serum, nasal and bronchial swab and from inguinal lymphoid samples. Specific humoral immunity was evaluated by ELISA. M-ChS + PRC-antigens measured between 1.3–10 μm and presented low Pdi and negative zeta potential, probably due to S (4.26%). Importantly, the 1-EMV protected 90% of challenged animals against PCV2 and Mhyop and 100% against Mhyor. A significant increase in antibody was observed for Mhyor (1-EMV and 2-EMV) and Mhyop (2-EMV), compared with 4-Commercial-vaccine. No difference in antibody levels between 1-EMV and 4-Commercial-vaccine for PCV2-Mhyop was observed. Conclusion: The results demonstrated the effectiveness of the first EMV with M-ChS + PRC-antigens in pigs, which were challenged with Mhyor, PCV2 and Mhyop, evidencing high protection for Mhyor, which has no commercial vaccine available. | |
dc.description.uri | https://www-scopus-com.recursosbiblioteca.unab.cl/record/display.uri?eid=2-s2.0-85194107458&origin=resultslist&sort=plf-f&src=s&nlo=&nlr=&nls=&sid=dbd85ca00ec1299adff19f78e4cdb00d&sot=aff&sdt=cl&cluster=scofreetoread%2c%22all%22%2ct&sl=34&s=AF-ID%2860002636%29+AND+SUBJAREA%28IMMU%29&relpos=6&citeCnt=0&searchTerm= | |
dc.identifier.citation | Vaccines Open Access Volume 12, Issue 5 May 2024 Article number 550 | |
dc.identifier.doi | 10.3390/vaccines12050550 | |
dc.identifier.issn | 2076393X | |
dc.identifier.uri | https://repositorio.unab.cl/handle/ria/58601 | |
dc.language.iso | en | |
dc.publisher | Multidisciplinary Digital Publishing Institute (MDPI) | |
dc.rights.license | CC BY 4.0 ATTRIBUTION 4.0 INTERNATIONAL | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
dc.subject | chitosan sulphated | |
dc.subject | heparan sulfate receptors | |
dc.subject | microparticles | |
dc.subject | mimetic | |
dc.subject | Mycoplama hyopneumoniae | |
dc.subject | Mycoplama hyorhinis | |
dc.subject | PCV2 | |
dc.subject | PRC | |
dc.subject | vaccine | |
dc.title | Design of a New Vaccine Prototype against Porcine Circovirus Type 2 (PCV2), M. hyopneumoniae and M. hyorhinis Based on Multiple Antigens Microencapsulation with Sulfated Chitosan | |
dc.type | Artículo |
Archivos
Bloque original
1 - 1 de 1
No hay miniatura disponible
- Nombre:
- Design-of-a-New-Vaccine-Prototype-against-Porcine-Circovirus-Type-2-PCV2-M-hyopneumoniae-and-M-hyorhinis-Based-on-Multiple-Antigens-Microencapsulation-with-Sulfated-Chitosan.pdf
- Tamaño:
- 2.08 MB
- Formato:
- Adobe Portable Document Format
- Descripción:
- TEXTO COMPLETO EN INGLÉS
Bloque de licencias
1 - 1 de 1
No hay miniatura disponible
- Nombre:
- license.txt
- Tamaño:
- 1.71 KB
- Formato:
- Item-specific license agreed upon to submission
- Descripción: